3-24127610-C-T
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_001354712.2(THRB):c.1033G>A(p.Gly345Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G345V) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001354712.2 missense
Scores
Clinical Significance
Conservation
Publications
- thyroid hormone resistance, generalized, autosomal dominantInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- resistance to thyroid hormone due to a mutation in thyroid hormone receptor betaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- thyroid hormone resistance, generalized, autosomal recessiveInheritance: AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| THRB | NM_001354712.2 | c.1033G>A | p.Gly345Ser | missense_variant | Exon 10 of 11 | ENST00000646209.2 | NP_001341641.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Thyroid hormone resistance, generalized, autosomal dominant Pathogenic:2
Variant summary: THRB c.1033G>A (p.Gly345Ser) results in a non-conservative amino acid change located in the Nuclear hormone receptor, ligand-binding domain (IPR000536) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251448 control chromosomes (gnomAD). c.1033G>A has been reported in the literature in multiple individuals affected with Thyroid Hormone Resistance, Generalized, Autosomal Dominant (Adams_1992, Alberobello_2011), and was found segregating with disease in one family (Adams_1992). These data indicate that the variant is very likely to be associated with disease. Experimental evidence obtained from Luciferase reporter assays found that the variant could not properly activate response reporters with normal T3 levels (Adams_1992) and required far higher levels of T3 to induce a response (Wan_2005), indicating that the variant receptor had poor affinity for its ligand. One ClinVar submitter has assessed the variant since 2014: the variant was classified as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
not provided Pathogenic:1
The variant has been reported to cosegregate in a family affected with generalized resistance to thyroid hormone in the published literature (PMID: 7200565 (1982), 1563081 (1992), 8319599 (1993)). Functional studies indicated this variant is functionally deficient and showed dominant negative activity (PMID: 1563081 (1992), 7838159 (1994), 15802373 (2005)). Based on the available information, this variant is classified as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at